Literature DB >> 15233379

Antagonism by local anesthetics of sodium channel activators in the presence of scorpion toxins: two mechanisms for competitive inhibition.

Stanley Lee Son1, Kin Wong, Gary Strichartz.   

Abstract

1. The interaction of veratridine (VTD), a Na+ channel activator, scorpion alpha-toxin (LQ), an open state Na+ channel stabilizer, and the local anesthetic, lidocaine (LID), a channel inhibitor, at the neuronal sodium channel was assessed by measuring VTD-dependent slow depolarizations of frog sciatic nerve using the sucrose-gap method. 2. The slow depolarizing action of veratridine was potentiated more than 10-fold by the peptide LQ toxin, whereas its competitive inhibition by lidocaine was unchanged by LQ. 3. We conclude that the antagonism between VTD and a LID molecule during slow depolarization is allosteric, involving a trapping of the Na+ channel by LID in the inactivated state that has a very low affinity for VTD. 4. The binding of VTD to the open state of the channel, which is stabilized by LQ, may be inhibited by orthosteric competition at overlapping sites since both LID and VTD bind avidly and rapidly to open channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233379     DOI: 10.1023/b:cemn.0000023630.16308.54

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  49 in total

1.  Kinetics of local anesthetic inhibition of neuronal sodium currents. pH and hydrophobicity dependence.

Authors:  D M Chernoff; G R Strichartz
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

2.  A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels.

Authors:  R S Sheldon; N J Cannon; H J Duff
Journal:  Circ Res       Date:  1987-10       Impact factor: 17.367

Review 3.  Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.

Authors:  W A Catterall
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

4.  Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers.

Authors:  C Nau; S Y Wang; G R Strichartz; G K Wang
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

5.  Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.

Authors:  R J Hill; H J Duff; R S Sheldon
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

6.  Binding affinity and stereoselectivity of local anesthetics in single batrachotoxin-activated Na+ channels.

Authors:  G K Wang
Journal:  J Gen Physiol       Date:  1990-11       Impact factor: 4.086

7.  Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.

Authors:  G K Wang; R Simon; D Bell; W M Mok; S Y Wang
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

8.  Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.

Authors:  R S Sheldon; R J Hill; M Taouis; L M Wilson
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

9.  Relation between veratridine reaction dynamics and macroscopic Na current in single cardiac cells.

Authors:  X G Zong; M Dugas; P Honerjäger
Journal:  J Gen Physiol       Date:  1992-05       Impact factor: 4.086

10.  Veratridine modifies open sodium channels.

Authors:  S Barnes; B Hille
Journal:  J Gen Physiol       Date:  1988-03       Impact factor: 4.086

View more
  2 in total

1.  PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.

Authors:  Lingxin Wang; Shannon G Zellmer; David M Printzenhoff; Neil A Castle
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

2.  Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation.

Authors:  Lingxin Wang; Shannon G Zellmer; David M Printzenhoff; Neil A Castle
Journal:  Br J Pharmacol       Date:  2015-10-15       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.